Cancer Medicines Forum workshop
5 April 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.
The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.
Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam
Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.
Next events
26th Workshop on Methods in Clinical Cancer Research (MCCR)
13 June - 18 June
Sint Michielsgestel, Netherlands
EORTC Pathobiology Autumn Group Meeting 2026
3 September - 4 September
Gmunden, Austria
EORTC Gastrointestinal Tract Cancer Group Autumn Meeting 2026
4 September - 5 September
Oxford, UK
EORTC Thyroid Cancer Group Autumn Meeting 2026
4 September
Porto, Portugal
SISAQOL pilot in-person training 2026
22 September - 23 September
Zagreb, Croatia
